159 related articles for article (PubMed ID: 37896163)
1. Efficacy of Apremilast Gels in Mouse Model of Imiquimod-Induced Psoriasis Skin Inflammation.
Silva-Abreu M; Sosa L; Espinoza LC; Fábrega MJ; Rodríguez-Lagunas MJ; Mallandrich M; Calpena AC; Garduño-Ramírez ML; Rincón M
Pharmaceutics; 2023 Sep; 15(10):. PubMed ID: 37896163
[TBL] [Abstract][Full Text] [Related]
2. Nanocrystal-based gel of apremilast ameliorates imiquimod-induced psoriasis by suppressing inflammatory responses.
Parmar PK; Sharma N; Wasil Kabeer S; Rohit A; Bansal AK
Int J Pharm; 2022 Jun; 622():121873. PubMed ID: 35640806
[TBL] [Abstract][Full Text] [Related]
3. Formulation characterization of lecithin organogel as topical drug delivery system for psoriasis: In-vitro permeation and preclinical evaluation.
Bule P; Kadkanje P; Kshirsagar R; Puppala ER; Naidu VGM; Chella N
Drug Dev Res; 2024 May; 85(3):e22191. PubMed ID: 38685610
[TBL] [Abstract][Full Text] [Related]
4. CD44 Assists the Topical Anti-Psoriatic Efficacy of Curcumin-Loaded Hyaluronan-Modified Ethosomes: A New Strategy for Clustering Drug in Inflammatory Skin.
Zhang Y; Xia Q; Li Y; He Z; Li Z; Guo T; Wu Z; Feng N
Theranostics; 2019; 9(1):48-64. PubMed ID: 30662553
[No Abstract] [Full Text] [Related]
5. Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis.
Schafer PH; Parton A; Gandhi AK; Capone L; Adams M; Wu L; Bartlett JB; Loveland MA; Gilhar A; Cheung YF; Baillie GS; Houslay MD; Man HW; Muller GW; Stirling DI
Br J Pharmacol; 2010 Feb; 159(4):842-55. PubMed ID: 20050849
[TBL] [Abstract][Full Text] [Related]
6. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis.
Pincelli C; Schafer PH; French LE; Augustin M; Krueger JG
J Drugs Dermatol; 2018 Aug; 17(8):835-840. PubMed ID: 30124722
[TBL] [Abstract][Full Text] [Related]
8. Gentiopicroside-Loaded Chitosan Nanoparticles Inhibit TNF-α-Induced Proliferation and Inflammatory Response in HaCaT Keratinocytes and Ameliorate Imiquimod-Induced Dermatitis Lesions in Mice.
Zhao K; Pu S; Sun L; Zhou D
Int J Nanomedicine; 2023; 18():3781-3800. PubMed ID: 37457802
[TBL] [Abstract][Full Text] [Related]
9. Phosphodiesterase 4 in inflammatory diseases: Effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4/CD271 complex.
Schafer PH; Truzzi F; Parton A; Wu L; Kosek J; Zhang LH; Horan G; Saltari A; Quadri M; Lotti R; Marconi A; Pincelli C
Cell Signal; 2016 Jul; 28(7):753-63. PubMed ID: 26806620
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous delivery of α-melanocyte-stimulating hormone for the treatment of imiquimod-induced psoriasis.
Shah PP; Desai PR; Boakye CH; Patlolla R; Kikwai LC; Babu RJ; Singh M
J Drug Target; 2016; 24(6):537-47. PubMed ID: 26582563
[TBL] [Abstract][Full Text] [Related]
11. Anoctamin1 Induces Hyperproliferation of HaCaT Keratinocytes and Triggers Imiquimod-Induced Psoriasis-Like Skin Injury in Mice.
Choi MR; Kim HD; Cho S; Jeon SH; Kim DH; Wee J; Yang YD
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281197
[TBL] [Abstract][Full Text] [Related]
12. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
[TBL] [Abstract][Full Text] [Related]
13. The Extracellular Vesicles from the Commensal Staphylococcus Epidermidis ATCC12228 Strain Regulate Skin Inflammation in the Imiquimod-Induced Psoriasis Murine Model.
Gómez-Chávez F; Cedillo-Peláez C; Zapi-Colín LA; Gutiérrez-González G; Martínez-Torres I; Peralta H; Chavez-Galan L; Avila-Calderón ED; Contreras-Rodríguez A; Bartolo-Aguilar Y; Rodríguez-Martínez S; Cancino-Diaz ME; Cancino-Diaz JC
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884834
[TBL] [Abstract][Full Text] [Related]
14. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells.
Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC
J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999
[TBL] [Abstract][Full Text] [Related]
15. Apremilast increases IL-10-producing regulatory B cells and decreases proinflammatory T cells and innate cells in psoriatic arthritis and psoriasis.
Mavropoulos A; Zafiriou E; Simopoulou T; Brotis AG; Liaskos C; Roussaki-Schulze A; Katsiari CG; Bogdanos DP; Sakkas LI
Rheumatology (Oxford); 2019 Dec; 58(12):2240-2250. PubMed ID: 31209492
[TBL] [Abstract][Full Text] [Related]
16. Dang-Gui-Liu-Huang Tang a traditional herbal formula, ameliorates imiquimod-induced psoriasis-like skin inflammation in mice by inhibiting IL-22 production.
Nguyen LTH; Ahn SH; Nguyen UT; Yang IJ
Phytomedicine; 2018 Aug; 47():48-57. PubMed ID: 30166108
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits imiquimod-induced psoriasis-like inflammation by inhibiting IL-1beta and IL-6 production in mice.
Sun J; Zhao Y; Hu J
PLoS One; 2013; 8(6):e67078. PubMed ID: 23825622
[TBL] [Abstract][Full Text] [Related]
18. 18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Gao J; Guo J; Nong Y; Mo W; Fang H; Mi J; Qi Q; Yang M
BMC Pharmacol Toxicol; 2020 Jun; 21(1):41. PubMed ID: 32493482
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
20. The phosphodiesterase 4 inhibitor apremilast inhibits Th1 but promotes Th17 responses induced by 6-sulfo LacNAc (slan) dendritic cells.
Oehrl S; Prakash H; Ebling A; Trenkler N; Wölbing P; Kunze A; Döbel T; Schmitz M; Enk A; Schäkel K
J Dermatol Sci; 2017 Aug; 87(2):110-115. PubMed ID: 28499587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
